Document is current

Any future updates will be listed below

Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy

Crossref DOI link: https://doi.org/10.1038/s41598-022-22668-1

Published Online: 2022-10-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark